Low Dose Naltrexone
-
Reimagining LDN – How Low Dose Naltrexone Could Reshape Treatments for Autoimmune Diseases
Low Dose Naltrexone (LDN) is gaining attention as a promising option in the fight against autoimmune diseases. Originally developed for treating opioid addiction, LDN’s potential to modulate the immune system has sparked interest in the medical community. Autoimmune conditions, from rheumatoid arthritis to multiple sclerosis, affect millions and often lack treatments that are both effective and safe for long-term use.…
Read More »